Patients epoprostenol. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Pulmonary Artery

Diseases7

Hypertension, Pulmonary Pulmonary Veno-Occlusive Disease Hemangioma, Capillary Heart Septal Defects Hypertension, Portal Connective Tissue Diseases Pulmonary Embolism

Chemicals and Drugs18

Epoprostenol Antihypertensive Agents Iloprost Tolazoline Preservatives, Pharmaceutical Sulfones Vasodilator Agents Purines Sulfonamides Acenocoumarol Excipients Piperazines Prostaglandins Platelet Aggregation Inhibitors Isoxazoles Receptors, Epoprostenol Adenosine Diphosphate Anticoagulants

Analytical, Diagnostic and Therapeutic Techniques and Equipment22

Drug Storage Infusions, Intravenous Administration, Intravenous Heart-Lung Transplantation Drug Stability Infusions, Parenteral Treatment Outcome Lung Transplantation Blood Pressure Bleeding Time Drug Therapy, Combination Cardiac Output Administration, Inhalation Follow-Up Studies Injections, Intravenous Infusions, Intra-Arterial Drug Administration Schedule Drug Evaluation Administration, Oral Angiography Retrospective Studies Survival Rate

Phenomena and Processes11

Hemodynamics Exercise Tolerance Vascular Resistance Pulmonary Circulation Pulmonary Wedge Pressure Blood Pressure Bleeding Time Platelet Aggregation Cardiac Output Dose-Response Relationship, Drug Ventricular Function, Right

Disciplines and Occupations1

Chemistry, Pharmaceutical

Information Science1

Health Care4

Treatment Outcome Follow-Up Studies Retrospective Studies Survival Rate

Geographicals1

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care Geographicals

Epoprostenol Hypertension, Pulmonary Antihypertensive Agents Drug Storage Iloprost Infusions, Intravenous Administration, Intravenous Pulmonary Veno-Occlusive Disease Hemodynamics Tolazoline Exercise Tolerance Preservatives, Pharmaceutical Sulfones Hemangioma, Capillary Vasodilator Agents Heart-Lung Transplantation Purines Vascular Resistance Pulmonary Circulation Sulfonamides Acenocoumarol Pulmonary Artery Pulmonary Wedge Pressure Drug Stability Heart Septal Defects Hypertension, Portal Chemistry, Pharmaceutical Infusions, Parenteral Treatment Outcome Excipients Lung Transplantation Piperazines Blood Pressure Connective Tissue Diseases Bleeding Time Prostaglandins Drug Therapy, Combination Platelet Aggregation Cardiac Output Administration, Inhalation Follow-Up Studies Injections, Intravenous Platelet Aggregation Inhibitors Dose-Response Relationship, Drug Isoxazoles Receptors, Epoprostenol Infusions, Intra-Arterial Drug Administration Schedule Ventricular Function, Right Drug Evaluation Adenosine Diphosphate Anticoagulants Pulmonary Embolism Administration, Oral Angiography Retrospective Studies Japan Survival Rate

No FAQ available that match "patients epoprostenol"